Nantahala Capital Management, LLC
Position in ABEO — Abeona Therapeutics Inc.
CIK 1472322
New Canaan, CT
Position in ABEO
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$31,743,508
+$9,285,036 QoQ
Shares Held
5,136,490
+2.5% QoQ
Ownership
8.98%
of shares outstanding
% of Portfolio
1.93%
of 13F equity value
Holder Rank
#1
of 125 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABEO Over Time
Shares Held
Position Value (USD)
Derivatives in ABEO
reported options exposure · as of Jun 30, 2026CallValue
$6,303,600
CallShares
1,020,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nantahala Capital Management, LLC holds $620,287,047 across 52 Biotechnology names. ABEO ranks #4 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SVRA |
Savara Inc
|
6,976,810 | $42,977,149 | |
| 2 | AVTX |
Avalo Therapeutics, Inc.
|
1,862,250 | $34,414,380 | |
| 3 | LBRX |
Lb Pharmaceuticals Inc
|
1,052,894 | $34,171,674 | |
| 4 | ABEO |
Abeona Therapeutics Inc.
This page
|
5,136,490 | $31,743,508 | |
| 5 | ZVRA |
Zevra Therapeutics, Inc.
|
1,797,476 | $25,775,805 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
820,481 | $22,136,577 | |
| 7 | QURE |
uniQure N.V.
|
455,660 | $20,987,699 | |
| 8 | AURA |
Aura Biosciences, Inc.
|
2,951,030 | $20,952,313 |
All Filings in ABEO
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,303,600 | 1,020,000 | Call | Sole | 2026-08-19 | |
| 2026-06-30 | $31,743,508 | 5,136,490 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $4,569,600 | 1,020,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $22,458,472 | 5,013,052 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,740,400 | 520,000 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $26,155,284 | 4,963,052 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $24,101,431 | 4,564,665 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $2,745,600 | 520,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $2,953,600 | 520,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $24,819,697 | 4,369,665 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,706,886 | 3,509,850 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $2,475,200 | 520,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $2,896,400 | 520,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $19,657,721 | 3,529,214 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,286,400 | 520,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $21,694,265 | 3,432,637 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,204,800 | 520,000 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $14,712,956 | 3,470,037 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,770,000 | 520,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $16,752,140 | 2,310,640 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,605,200 | 520,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $11,273,762 | 2,250,252 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $218,920 | 52,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $9,673,712 | 2,297,794 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,649,576 | 1,401,880 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $80,600 | 20,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $4,028,863 | 1,428,675 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $840,011 | 272,731 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||